Karthik Devarajan

Appearances

OPTIMAL TIME TO SURGERY AFTER NEOADJUVANT THERAPY IN PANCREATIC ADENOCARCINOMA: IS THERE AN IDEAL WINDOW?
Date
May 9, 2023
Pancreatic ductal adenocarcinoma (PDAC) exists in several morphological subtypes differing in prognostic significance. However, to date, a clinico-morphological correlation of these subtypes in the context of neoadjuvant therapy (NAT) has not been performed…
Presenter
Andrew Crocker
Speakers
Leah Winer
Eileen O’Halloran
Dany Barrak
Karthik Devarajan
Sanjay Reddy
SMOKING HISTORY IS ASSOCIATED WITH REDUCED EFFICACY OF NEOADJUVANT THERAPY IN PANCREATIC ADENOCARCINOMA
Date
May 9, 2023
Pancreatic ductal adenocarcinoma (PDAC) exists in several morphological subtypes differing in prognostic significance. However, to date, a clinico-morphological correlation of these subtypes in the context of neoadjuvant therapy (NAT) has not been performed…
Presenter
Rita Akumuo
Speakers
Sai Reddy
Karthik Devarajan
Dany Barrak
Jason Castellanos
Jeffrey Farma
Sanjay Reddy
Anthony Villano